Objective: The goal of this study was to explore the feasibility and potential efficacy of providing computer-assisted cognitive behavior therapy (CCBT) after an index course of electroconvulsive therapy (ECT) to prevent relapse.
M
ajor depressive disorder (MDD) is the most common mental illness and is associated with significant morbidity and mortality worldwide. 1 Major depressive disorder affects many persons of all ages and backgrounds and has been shown to substantially impair work productivity, 2 costing the United States more than $210 billion per year in 2010. All Food and Drug Administrationapproved oral antidepressants used as monotherapies generally only have modest benefits, with response rates (in relatively uncomplicated, nonchronic forms of MDD) of approximately 50% and remission rates of 30% to 35%. [3] [4] [5] [6] Treatment-resistant depression (TRD) is often defined as MDD that does not respond or remit to 1 or more adequate antidepressant trials 7 ; TRD comprises one third of all patients with MDD. 8 In the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, remission rates for patients who did not remit after the first treatment level were 31%, 14%, and 13% for the second, third, and fourth levels, respectively. 8 Treatment-resistant depression contributes substantially to the disease burden of MDD, with increased costs of health care and productivity loss of $9529 annually compared with treatment-responsive depression. 9 Electroconvulsive therapy (ECT) is among the most effective treatment options for MDD and TRD, with response rates of 80% to 90% when used as a first-line treatment and response rates of 50% to 60% in treatment-resistant depression. 10 However, relapse (defined as return of depressive symptoms within 6 months) after ECT remains a major clinical problem. Relapse rates have been reported as high as 84% with no maintenance therapy 11 and typically range from 32% to 50% even with post-ECT pharmacotherapy or maintenance ECT. [11] [12] [13] [14] In most clinical trials, relapse was most commonly seen within the first 2 months after treatment. 10, 11, 13 Cognitive behavioral therapy (CBT) is an effective adjunctive treatment to classic antidepressant medications 15 and has been shown to be highly effective in relapse prevention after a course of psychotherapy or antidepressant medication. [16] [17] [18] [19] The goal of CBT is to learn new patterns of thinking and extinguish pathological and distorted thought patterns. Hence, CBT may be an effective relapse prevention strategy for patients who respond or remit after ECT. There are few studies investigating the effects of combining ECT and psychotherapy aimed at preventing relapse/ recurrence, 20 in part because of the cognitive problems traditionally associated with ECT. However, recent advances in technique (ie, ultrabrief pulse width, right unilateral) 21 have reduced the cognitive burden associated with ECT and may allow for psychotherapy shortly after a course of ECT. Indeed, at least 2 studies, including one by our group, have demonstrated the feasibility and potential efficacy of this approach, both of which used CBT to prevent relapse after ECT. 22, 23 High-quality CBT, however, is not always readily available in the community. For instance, in our state of approximately 3.6 million people, there are only 9 CBT therapists with certification by the Beck Academy of Cognitive Therapy. 24 Because of the dearth of well-trained CBT therapists and in an effort to more widely disseminate the powerful effects of this psychotherapy modality, computer-assisted versions of CBT have been developed, with clinical trials showing efficacy comparable with traditional CBT in select populations. [25] [26] [27] As a follow-up to our previous study, 22 the primary objectives of the present study were to investigate the feasibility and potential efficacy of computer-assisted CBT (CCBT) after ECT to prevent relapse in an attempt to possibly identify a relapse prevention strategy that is easy to disseminate and can be tested in larger scale studies.
MATERIALS AND METHODS

Subjects
The study was conducted at Yale Psychiatric Hospital and was approved by the local institutional review board before commencement and was registered on clinicaltrials.gov (NCT02176473). All subjects provided written informed consent. Patients aged 21 to 75 years diagnosed with a major depressive episode (unipolar or bipolar depression) who had achieved response or remission after ECT delivered at the Yale-New Haven Hospital Interventional Psychiatry Service and were considered appropriate candidates for CBT were recruited to participate. Subjects were excluded if they had current or recent (within 6 months) substance use disorder; comorbid axis II pathology that was predominant to their depressive episode; psychotic disorder (not including major depressive episode with psychotic features); suicidal ideation with a plan; or did not possess basic computer skills or have regular access to a computer.
Electroconvulsive Therapy Treatments
Similar to our previous study, 22 ECT treatments were provided under general anesthesia in an ECT treatment suite of a university hospital with a MECTA Spectrum 5000Q device (MECTA Corporation, Tualatin, Ore). For each treatment, quality of seizure morphology was confirmed by the attending psychiatrist reading the electroencephalographic strip. Stimulus threshold was titrated at the first treatment session, beginning at approximately 1 J, and increasing the train duration by approximately 1 second with each subsequent stimulus until seizure was achieved. Subsequent treatments used energy levels 50% above seizure threshold for patients treated with bitemporal (BT) placement or 5 to 6 times seizure threshold for patients treated with right unilateral lead (RUL) placement. Based on previous research suggesting lower cognitive adverse effects with low-pulse widths, 21 the pulse width of right unilateral treatments was maintained as low as possible (ie, 0.30 ms); the pulse width for BT was held constant at 0.50 milliseconds. The pulse amplitude was held constant at 800 mA. Subjects who showed little or no response after 6 to 7 RUL treatments were subsequently switched to BT treatments. Initial electrode placement is almost always RUL in our community except for cases of catatonia or clinically significant suicidal ideation.
Cognitive Behavioral Therapy Program
As is the standard practice at our hospital, ECT patients gradually transition from receiving ECT treatments 3 times weekly to a continuation/maintenance schedule. Once the frequency of ECT was weekly or less frequent, subjects who consented to the study were enrolled in a well-validated CCBT program called Good Days Ahead (GDA, Empower Interactive, Inc, San Francisco, CA). This program consists of 9 computerized sessions, each 30 to 45 minutes in length, with homework assignments between sessions, similar to traditional CBT. Randomized trials using this software program have shown efficacy similar to traditional CBT when supported by brief (25 min) in-person psychotherapy sessions weekly or every other week. Remission rates are approximately 39% to 40% after a full course of either traditional or CCBT in populations of MDD. [25] [26] [27] [28] The program focuses on the same principles of traditional CBT, namely, "identifying, labeling, and modifying automatic thoughts; the link between thought and action; identifying and modifying schemas; and identifying and correcting cognitive errors." 26 The software provides modeling of CBT principles (in the form of short videos), enables an interactive forum by giving users feedback based on responses to questions, and encourages participants to apply the skills learned in CBT to their situations. Subjects completed the CCBT in their own home at their own pace, but were asked to do at least 1 lesson per week such that all 9 lessons would be completed in the first 2 months, the time period associated with the highest rates of relapse. During the first 2 months of the study, brief supportive telephone calls were made weekly to encourage compliance, answer questions, and reinforce CBT principles. All patients continued to receive pharmacotherapy, psychotherapy, or ECT maintenance therapy as tolerated and recommended by their treating psychiatrist.
Assessments and Outcomes
At the conclusion of the index course of ECT and before starting CBT, baseline ratings of depression were completed using the Montgomery-Åsberg Depression Rating Scale (MADRS), 29 the Beck Depressive Inventory II (BDI), 30 the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS), 31 and the Clinical Global Impression scale. 32 The BDI and QIDS were administered at the completion of every other lesson (approximately weekly) for the first 4 weeks and monthly thereafter. The MADRS was administered on a monthly basis. Similar to other research, 33 relapse was defined as having a MADRS score of 20 or more at final visit, hospitalization for depression or suicidality, or needing another index course of ECT treatments (3 times weekly). Because this was a pilot feasibility study, the principal question we aimed to answer was whether subjects would actually complete the CBT lessons online in their own homes on their own time. This was assessed via completion rates of CBT sessions as well as total hours logged on to the program. To draw preliminary inferences regarding potential efficacy, our data were qualitatively compared with a previous study by our group examining the feasibility of traditional CBT in an open-label pilot study 22 as well as historical rates of relapse from the literature.
RESULTS
Demographic and Clinical Information
Thirty-six potential subjects were screened for participation in the study, with 15 (80% women) subjects who eventually enrolled and participated in at least online CBT session (Fig. 1) . Subjects were well educated and mostly married ( Table 1 ). The mean (SD) age was 48.1 (10.9) years (range, 27-70). All were taking some form of concomitant psychotropic medication. Although all subjects had prior psychotherapy treatment, only 2 (13%) had prior experience with CBT. Thirteen (87%) subjects continued psychotherapy after the acute course of ECT, whereas 1 (6.7%) initiated a new group psychotherapy course after acute treatment, and 1 (6.7%) did not continue psychotherapy. Three subjects (20%) withdrew from the study prematurely, all because of relapse (2 subjects relapsed 1 mo after completion of their index ECT course and 1 subject relapsed at 2 mo). Progress of those subjects who withdrew was not monitored once participation was discontinued. All subjects who withdrew relapsed before withdrawal. Hence, using the last observation carried forward (LOCF) method is a conservative approach to the analysis of their missing data.
Electroconvulsive Therapy Treatments
As is the standard practice in our community, all patients who demonstrated clinical response received recommendations to undergo continuation ECT for the 6 months after index course. Six of the original 15 patients underwent continuation ECT throughout the entire 6-month study follow-up period, with 5 additional participants discontinuing ECT prematurely during the continuation phase. The mean number of treatments during the index course and 6-month follow-up are given in Table 1 . Most patients (14/15) began ECT as right unilateral, ultrabrief pulse width, with 3 patients switching to the BTelectrode placement technique partway through their index course to increase efficacy. One patient (who subsequently withdrew because of relapse) reported that cognitive problems impaired her ability to engage in the CCBT course.
Computer-Assisted CBT Treatment Compliance
Subjects were asked to complete at least 1 online lesson every week, such that all 9 lessons would be complete during the initial 2 months of the study period (when relapse rates are highest). The mean (SD) number of online CBT lessons completed throughout the study was 7.6 (1.7) or 84%. The mean (SD) number completed during the first 2 months was 6.5 (1.8) or 72%. The mean (SD) time spent working on the online program was 8.4 (3.9) hours. The mean (SD) time spent online during the first 2 months was 6.8 (3.2) hours. Given that participants were asked to complete at least 1 lesson per week, an episode of noncompliance was declared when a participant did not login to the program for a period of at least 2 weeks. Most (13/15) participants had at least 1 episode of noncompliance. The mean (SD) number of episodes of noncompliance was 1.5 (1.1). There were no correlations between age and CCBT completion rate or age and time spent working on the online program.
Clinical Outcomes
Generally, subjects maintained gains achieved during the acute phase of ECT, analyzing both completers only and intention to treat (Fig. 2) . Including the 3 subjects who withdrew prematurely, most subjects (10/15) had lower or equivalent MADRS scores at their final visit compared with their baseline (immediately post-ECT) visit. Including only those who completed the study, 10 of 12 had MADRS scores at 6-month follow-up less than or equal to the baseline visit. Similar results were seen using selfreport measures. Among all who began the study and completed at least 1 CBT lesson (intention to treat), most (12/15) had lower or equivalent QIDS scores at final compared with baseline visit; 13 of 15 reported a lower or equivalent BDI score at the final compared with baseline visit. Five subjects had achieved remission (MADRS ≤ 10) by the conclusion of the index course of ECT; all 5 of these subjects retained remission by study end at 6 months, with 1 additional subject achieving remission by study end. Five participants relapsed during the course of the study, with 3 doing so within 2 months and 2 at the last visit (Fig. 3) . Compared with those who did not relapse; participants who eventually relapsed completed significantly fewer CCBT lessons in total (6.4 vs 8.3, t = −2.37, P = 0.034) and during the first 2 months (5.2 vs 7.2, t = −2.33, P = 0.037). There was no difference in clinical outcomes or CBT completion rates between those who received BT ECT compared with those who received RUL ECT.
DISCUSSION
This preliminary study demonstrates that it is feasible to institute adjunctive CCBT in a population of patients who have recently finished an index course of ECT. In addressing our primary question of feasibility, the compliance rates of 84% total lesson completion and 72% lesson completion within the first 2 months suggest that the majority of the subjects were able to complete the CBT lessons in their own homes, on their own times with minimal support structure. Our data also suggest that CCBT may be beneficial in treating residual symptoms as well as maintaining remission. Traditionally, it has been thought that psychotherapeutic interventions were not appropriate for ECT patients because cognitive adverse effects would limit the ability to engage in such interventions. However, the data presented here suggest otherwise. Whereas 1 patient reported cognitive adverse effects that limited her ability to engage in CCBT, the majority (93%) of participants in this study were able to engage in CCBT. In addition, experience from our prior study using traditional CBT also suggests that patients can engage meaningfully in traditional CBT immediately after a course of ECT. 22 Furthermore, all subjects from the current study had prior psychotherapy experience and almost all continued or initiated new psychotherapy treatment shortly after the acute course of ECT. That only 2 subjects had previous exposure to CBT in a patient population of severe depression underscores the lack of availability of this effective psychotherapy modality. Time (h) spent logged in to CCBT program during the first 2 mo A major limitation of this study was the lack of rigorous neurocognitive assessments that could have more definitively showed that cognitive impairment from ECT did not interfere with CCBT. These data would also have been useful to assess any correlation between executive function and relapse after ECT because executive function is correlated with response to CBT. 34 It is important to note that the CCBT program used in this study was not designed as a stand-alone, online psychotherapy program but was intended to be used in conjunction with inperson CBT, reducing the total time required for therapistpatient interaction. However, because of funding constraints and the goal of examining conditions in which this could be more easily disseminated in most communities, it was used in this study with minimal support (brief phone calls on a weekly basis). Considering this limitation, compliance was generally high, especially in a population recently receiving ECT. On average, more than 80% of lessons were completed during the study period, with 72% of these being completed in the prescribed time period (the initial 2 months).
Although this was an open-label trial, our results compare favorably to historical data. In sum, most subjects had lower depression scores at their final visit compared with baseline (10/15 for MADRS, 12/15 for QIDS, and 13/15 for BDI). Although 33% of our total sample eventually relapsed (counting both remitters and responders), all (n = 5) subjects who achieved remission remained well at 6 months, with 1 additional subject achieving remission by study end. In large trials, historical rates of relapse of post-ECT remitted patients range from 31% to 50% at approximately 6 months with both continuation pharmacotherapy 11, 12, 35 or continuation ECT 12 as maintenance strategies. At least 1 smaller study has reported favorable relapse rates (32% at 1 y) among both remitters and responders using continuation ECT as a maintenance strategy. 33 Hence, it is possible that the CCBT intervention used in this study did not have a direct effect on the low rate of relapse among remitters. On the other hand, a prior randomized trial using group CBT as a maintenance strategy was superior to both continuation pharmacotherapy and continuation ECT 23 ; hence, it is also possible that CCBT could be an effective strategy or adjunctive treatment to maintain remission or response in ECT patients. Our results also are similar qualitatively to our previous study evaluating the feasibility and potential efficacy of traditional CBT after ECT, 22 although a direct comparison using a randomized design is needed to draw more meaningful conclusions regarding comparative efficacies of traditional and CCBT modalities in this clinical context. In our previous study, participants underwent a 12-week, in-person CBT course that began after the index course of ECT. The CBTwas concurrent with a continuation ECT course and was performed by therapists who had undergone training and certification from the Beck Academy of Cognitive Therapy. Among those who completed the CBT course, all had lower or equivalent BDI scores 9 months after the index course of ECT compared with their scores immediately after the ECT course, 22 which is similar to the current study. Although admittedly speculative at this point, it is possible that ECT may create a period of enhanced neuroplasticity 36 and hence afford an opportune window of time to institute a course of CBT with the aims of retraining negative thought patterns and core beliefs. The results of this study suggest that adjunctive CCBT was beneficial, continuing to lower depression severity and reducing relapse rates. Further evidence supporting this hypothesis was presented by our previous open-label study with standard in-person CBT 22 and a larger randomized controlled trial showing that group CBTwas superior to both medication and continuation ECT in preventing relapse. 23 There were several limitations to this phase treatment development study. A number of other factors may have contributed to the generally positive outcomes in this study, including concomitant medications or psychotherapy (which were not controlled), the natural course of the depressive illness, increased attention from research staff, or other concomitant psychosocial interventions. However, despite these limitations, the data suggest that the treatment was adopted and used by the large majority of the study participants and may have provided some clinical benefit in further reducing depression severity and reducing the rate of relapse. Considering the relative ease with which CCBT could be disseminated and the continuing problem of relapse post-ECT, larger controlled studies examining CCBT in reducing relapse after ECT are warranted.
